Omnii-1 showcases 8 biology applications, beats AlphaGenome on regulatory genomics benchmarks
exnx · x · 2026-10-21
A thread showcasing 8 applications of Omnii-1, a generalist genome language model claimed to outperform specialized models across biological domains: beating AlphaGenome on regulatory genomics benchmarks, generalizing to unseen modalities like 5hmC for early cancer detection, and designing functional proteins, antibodies, and personalized cancer vaccine candidates.
Benchmark tables in the figures show Omnii-1 leading ChromBPNet, Borzoï, and AlphaGenome across RNA-seq, CAGE, splicing, ATAC-seq, DNA methylation, and multiple QTL tasks. The model unifies 28 biological modalities spanning DNA, RNA, proteins, and epigenomics.
Related event: Omnii-1 launch: AI-designed phage given to human patient in world first(10 posts)→
More from Research
- Seqlet caller follow-up: credits for DeepLIFT contributors — jmschreiber91 · 2026-10-21
- Center for AI Safety Publishes Full Syllabus for Intro to ML Safety Course — ArtificialOther · 2026-10-21
- Seqlet caller gets 22x speedup: 167,750 loci drop from 7.8s to 0.35s — jmschreiber91 · 2026-10-21
- X trends: SophontAI's Holon-S1 predicts gene activity from cancer slides; decision models rise — iScienceLuvr · 2026-10-21
- NEJM AI study: LLM-recommended care costs up to 10x more than physician orders — dvir_a · 2026-10-21
- Nucleotide dependency analysis turns genomic language models into functional element detectors — jmschreiber91 · 2026-10-21